Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 22,019 shares at $52.94 ($1.2M) on 2010-10-25, disclosed to the SEC on 2010-10-27.
Scheduled sale ($1.2M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| ABT | SELL | 2014-03-04 | $117K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |